Investing Acceleration of RAD204 Phase 1 dose escalation trial May 12, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Fortnite applies to launch on Apple’s App Store after Epic Games court win May 12, 2025 Next Post Excellent Gold Intersections Verified at Kiimala Project May 12, 2025 Related Posts Top 5 Canadian Cobalt Stocks of 2025 August 19, 2025 Graphite Resource Expansion Sets Project up as World-Class August 19, 2025 Danielle DiMartino Booth: Fed’s Next Move as Dissent Builds, Where to Focus Now August 19, 2025
